CoChat

Alprazolam and diazepam: Addiction potential

Open access
Juergens, Steven · 1991 · Journal of Substance Abuse Treatment

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

Alprazolam and diazepam, the two most prescribed benzodiazepine anxiolytics in the United States, have potential for addictive use. The Drug Abuse Warning Network (DAWN) indicates they are the most mentioned benzodiazepines, and the National Household Survey indicates significant abuse of tranquilizers. Both drugs are rapidly absorbed and enter the brain tissue rapidly, leading to reinforcement. Alprazolam has a shorter half-life, which may lead to more withdrawal symptoms than diazepam. In experimental conditions, they are among the most reinforcing benzodiazepines. Each causes a withdrawal syndrome, but alprazolam withdrawal may be more severe and may occur after a shorter period of use. Adverse effects from their use are said to be rare, yet subtle negative consequences may be seen with some regularity. Alprazolam deserves special caution because of its relative newness, great popularity, reinforcing capabilities, relatively severe withdrawal syndrome, and reports of addiction and negative consequences of use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0740-5472(91)90026-7

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Research works printed but not linked: 5

  1. Guarino, J.L. & Griffiths, R.R. (1989). Alprazolam: Subjective ef- fects, behavioral effects, and abuse liability in drug abusers. The Pharmacologist, 30, 135.
  2. Ladewig, D., Banzinger, W., & Lowenheck, M. (1981). Tranquil- izer abuse-Results of a nationwide Swiss survey. Journal of Drug Research, (TNO), 6, 1132-l 137.
  3. Patterson, 1988, Alprazolam dependency: Use of clonazepam for withdrawal, Southern Medical Journal, 81, 836, 10.1097/00007611-198807000-00006 · DOI · Paper page
  4. Simonsen, L.L.P. (1989, April). Top 200 drugs of 1988: Branded new Rxs rise 4.0% and total Rxs move up 1.2%. Pharmacy Times, 40-48.
  5. In L.S. Harris (Ed.), Prob- /ems of drug dependence (pp. 375-376). NIDA Research Mono- graph No. 95, DHHS Publication No. (ADM) 90-1663.

Cited by

See all 56

Metadata

Authors
Juergens, S.
Affiliations
Virginia Mason Medical Center (US)
Corresponding author
Juergens, Steven
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
1991-01
Volume
8
Issue
1-2
Pages
43-51
ISSN
0740-5472 (ISSN-L)
OpenAlex
W2102188940
Cited by
46
References
72
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2018: 2 · 2017: 2 · 2016: 1 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
1.21
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Substance Abuse Treatment (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
alprazolam, diazepam, benzodiazepines, drug addiction, benzodiazepine misuse, withdrawal syndrome, drug reinforcement, adverse effects, anxiolytics
MeSH terms
Alprazolam, Diazepam, Humans, Risk Factors, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alprazolam and diazepam: Addiction potential. https://app.cochat.ai/papers/10.1016/0740-5472(91)90026-7
The paper
Juergens, S. (1991). Alprazolam and diazepam: Addiction potential. Journal of Substance Abuse Treatment. https://doi.org/10.1016/0740-5472(91)90026-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.